Eye on H1N1
- Previous Video: Oil Price No Longer Based on Fundamentals
- Next Video: Bullish on the Aussie Dollar
Airtime: ET
Manufacturers are having issues with yields from strains used to produce H1N1 vaccines, says Rhenu Bhuller, global VP of pharmaceuticals at Frost & Sullivan. She sheds light on what is happening, with guest host, Greg Bundy of AIMS Finance & CNBC's Martin Soong.
- Previous Video: Oil Price No Longer Based on Fundamentals
- Next Video: Bullish on the Aussie Dollar
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
